Shoreline Biosciences logo

Shoreline Biosciences

Los Angeles, CA

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.

shorelinebio.com

Company Details

Founded

2020

Employees

Between 50 - 100 employees

Raised

$183,000,000

Headquarters Location

Los Angeles, CA

Public

No

Acquired

No

CEO

Kleanthis G. XanthopoulosKleanthis G. Xanthopoulos

Founders

Dan S. Kaufman
Dan S. Kaufman
Steven Holtzman
Steven Holtzman
William Sandborn
William Sandborn
Kleanthis G. Xanthopoulos
Kleanthis G. Xanthopoulos
Marios Fotiadis
Marios Fotiadis

Company Collections

These are collections Shoreline Biosciences is a part of. Click on the collection name to view similar companies.

Shoreline Biosciences' Industries

Shoreline Biosciences' Tech Stack